Results 151 to 160 of about 577,115 (171)

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies. [PDF]

open access: yesMol Oncol
Ojala VK   +15 more
europepmc   +1 more source

The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation. [PDF]

open access: yesJ Neuroinflammation
Gryksa K   +4 more
europepmc   +1 more source

Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor-Resistant Head and Neck Squamous Cell Carcinoma. [PDF]

open access: yesCancer Res Commun
Silva FN   +7 more
europepmc   +1 more source

Immune responses to all ErbB family receptors detectable in serum of cancer patients

open access: yesOncogene, 1999
Employing NIH3T3 transfectants with individual human ErbB receptor coding sequences as recombinant antigen sources, we detected by immunoblot analysis specific immunoreactivity against all four ErbB receptors among 13 of 41 sera obtained from patients ...
Vincenzo Visco   +2 more
exaly   +2 more sources

ERBB receptors and cancer: the complexity of targeted inhibitors

open access: yesNature Reviews Cancer, 2005
ERBB receptor tyrosine kinases have important roles in human cancer. In particular, the expression or activation of epidermal growth factor receptor and ERBB2 are altered in many epithelial tumours, and clinical studies indicate that they have important ...
Nancy E Hynes
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Impact of ErbB Receptors and Anticancer Drugs against Breast Cancer: A Review

Current Pharmaceutical Biotechnology, 2022
Ankita Sahu, Manoj Kumar Yadav
exaly  

Home - About - Disclaimer - Privacy